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Abstract
Multimorbidity is increasingly the primary concern of healthcare systems globally with sub-
stantial implications for patient outcomes and resource cost. A critical knowledge gap exists
as to the magnitude of multimorbidity in primary care practice in low and middle income
countries with available information limited to prevalence. In India, primary care forms the
bulk of the health care delivery being provided through both public (community health cen-
ter) and private general practice setting. We undertook a study to identify multimorbidity pat-
terns and relate these patterns to severity among primary care attendees in Odisha state of
India. A total of 1649 patients attending 40 primary care facilities were interviewed using a
structured multimorbidity assessment questionnaire. Multimorbidity patterns (dyad and
triad) were identified for 21 chronic conditions, functional limitation was assessed as a proxy
measure of severity and the mean severity score for each pattern, was determined after
adjusting for age. The leading dyads in younger age group i.e. 18–29 years were acid peptic
disease with arthritis/ chronic back ache/tuberculosis /chronic lung disease, while older age
groups had more frequent combinations of hypertension + arthritis/ chronic lung disease/
vision difficulty, and arthritis + chronic back ache. The triad of acid peptic disease + arthritis
+ chronic backache was common in men in all age groups. Tuberculosis and lung diseases
were associated with significantly higher age-adjusted mean severity score (poorer func-
tional ability). Among men, arthritis, chronic backache, chronic lung disease and vision
impairment were observed to have highest severity) whereas women reported higher sever-
ity for combinations of hypertension, chronic back ache and arthritis. Given the paucity of
studies on multimorbidity patterns in low and middle income countries, future studies should
seek to assess the reproducibility of our findings in other populations and settings. Another
task is the potential implications of different multimorbidity clusters for designing care proto-
cols, as currently the protocols are disease specific, hardly taking comorbidity into account.
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Introduction
With increased life expectancy and better living conditions, the co-occurrence of multiple
chronic conditions, commonly referred to as ‘multimorbidity’ is being increasingly observed
among individuals globally [1]. Compared to comorbidity, multimorbidity, the concurrent
presence of two or more chronic conditions is independent of an underlying or index disease
[2]. The consequences of multimorbidity are manifold—individuals with multiple morbidities
experience an inferior quality of life, a poorer perception of their physical and mental health,
experience higher in-hospital mortality, longer length of hospital stay, incur higher healthcare
expenditure, and a lower functional capacity[3–5]. Evidence suggests that it is not the chronic
conditions by themselves that increase the resource cost. It is the number of types of condi-
tions, i.e multimorbidity which is responsible [6,7]The current knowledge of multimorbidity
is largely based on studies from western countries demonstrating the prevalence to be high
ranging from 30% in all adults to 60% among 65–74 year olds [8]. Moreover, initially thought
to be a geriatric phenomenon, several recent studies have demonstrated that younger adults
also exhibit a considerable prevalence of multimorbidity[9]. Ironically, existing care models
and the clinical guidelines for chronically ill patients are mostly focused on management of
single conditions separately though diseases are rarely presented in isolation[10].
Despite some conceptual differences, the most commonly used approach to express the
magnitude of multimorbidity has been simple counting of chronic conditions which provides
a measure of prevalence or use of indices like Charlston Comorbidity Index, which provides
more or less a weighted score [11]. However, multimorbidity is a complex phenomenon with a
labyrinth full of possible disease combinations; therefore, the use of a quantitative definition
has been used extensively to capture the patterns of diseases. The co-occurrence of diseases has
implications from a disease management point of view; the impact of multiple diseases may
compound and interact, and the summative features can be much more complicated than a
simple aggregation of individual illnesses. Since, the negative outcomes associated with multi-
morbidity are largely attributable to the clustering and typology of conditions, the coexistence
rather than the number is a matter of concern[6]. Thus, information on only prevalence by
simple count may not be sufficient enough to guide primary health services design; it is addi-
tionally important to examine the patterns for appropriate clinical management and adequate
understanding of the disease effect by researchers and policymakers.
Besides count and combinations of constituent conditions, the burden of multimorbidity
among those affected depends on the severity of chronic conditions, temporal evolution and
social factors as well [12,13]. Groups of conditions may have a synergistic effect on functional
ability, and specific diseases may be associated with difficulties in different functional tasks, a
complexity not captured through one-dimensional (simple count) or two-dimensional (count
and combinations) indices. Identifying particular combinations of diseases that have highest
effect on functional limitation can provide health and social care professionals with insights on
synergies and effects associated with coexisting diseases and design services accordingly[10].
Multidimensional indices that have incorporated severity (measured by functional limitation)
to estimate the magnitude multimorbidity have shown to be correlated well with health out-
comes including quality of life and mortality [6,14]. The recent global move on primary care-
led management of NCDs has emphasized the importance of patterns analysis in the multi-
morbidity research agenda. Yet, there are a far smaller number of studies assessing the severity
or functional limitation dimension of multimorbidity.
Surprisingly, especially in low and middle income countries, multimorbidity is an underex-
plored domain till date despite the rising prevalence of NCDs in these countries[8]. Little
research has investigated this entity in India, the second largest demography in the world. Our
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recent systematic review has revealed the rudimentary work on multimorbidity in South Asia
with conspicuous absence of any reports from Indian primary care[15]. Available estimates
mostly describe the prevalence confined to either a limited set of chronic conditions or specific
age groups. More so, no study had examined the patterns or severity within the ambit of multi-
ple morbidities thus potentially leading to inadequate information for care management. It is
not yet known how multimorbidity is distributed across age and sex group and what are the
commonly occurring combinations of chronic diseases in individuals and their outcomes.
This information is critical as traditionally, the health care systems in India have been config-
ured around the ideology of the infectious diseases and singular-morbidity oriented care
[16,17]. Thus, multimorbidity could be easily ignored by the clinician at the same time being
challenging to address. Primary care physicians are the first point of contact and the main pro-
viders of healthcare in the country. Given their continuity of care and coordinating role, these
settings are well suited for managing multiple chronic diseases. We therefore undertook a
study to examine the pattern and severity of multimorbidity in primary care patient popula-
tion in an Indian state having health indicators similar to the national average. The objectives
were—to describe the multimorbidity patterns, identify the commonly occurring combina-
tions (dyads and triads), analyze the age and gender-specific differences in the patterns and
assess functional limitation or severity across different patterns. It is expected that our findings
would provide primary care clinicians and policy makers with better clinical and epidemiolog-
ical understanding of multimorbidity for aligning care management.
Our research questions were:
• What are the common combinations of disease entities within multimorbidity among pri-
mary care patients?
• What is the level of severity in the leading combinations?
• What are the implications of our findings for future health care policy and practice?
Methods
Study design and participants
We undertook a cross sectional study in 40 primary care facilities (20 public and 20 private)
in Odisha state of India. A two-stage clustered stratified random sampling method was
adopted for recruiting health facilities. In the first stage, all 30 districts of the state were
divided into two clusters i.e. economically well-developed (20) and less-developed (10), as
per the state’s defined criteria[18]. From each cluster, districts were selected using stratified
sampling methods, comprising four districts from less-developed and six from the developed
districts. From each district, two community health centers (CHC) were randomly selected.
For every CHC, a corresponding private facility in the vicinity was randomly included thus
totaling to 20 private primary care facilities. We decided to include equal number of public
and private facilities, as according to the national sample survey report, nearly 50% popula-
tion in Odisha visited private facilities for any reported illness in addition or parallel to pub-
lic health services. [19].
As we did not have studies from India on prevalence of multimorbidity, the required sam-
ple size was calculated based on our pilot study while validating the multimorbidity assessment
tool. Considering that 23% of patients attending primary health care settings have multimor-
bidity[20], a sample of at least 1456 was needed to estimate this level of prevalence within rela-
tive precision error of 12.5% and design effect of 1.7. After accounting for 13% non- response
based on our pilot experience[20], the final required sample size was 1670. It was decided to
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divide this sample number equally between private and public health care facilities as per the
national sample survey report.
Data collection
In view of unavailability of proper medical records, information was obtained through struc-
tured exit interviews with patients attending outpatient unit of public and private primary
health care facilities. With no gold standard available to measure multimorbidity in India, we
developed and validated a structured tool—Multimorbidity Assessment Questionnaire for Pri-
mary Care (MAQ-PC)[20]. We followed a two-phase iterative process to design this compre-
hensive tool. The first phase involved the development of the questionnaire, selecting the
domains and their measurements, translating the questionnaire to local language for cultural
adaptability, and testing its comprehensibility. The second phase entailed reliability and valid-
ity testing. The detailed methodology for development and validation of our tool is already
described in another article.[20]. The socio-demographic section of the questionnaire elicited
information on age, gender, place of birth, residence, ethnicity, religion, educational level,
marital status, poverty status as per state guideline, current housing and household composi-
tion[21]. Multimorbidity assessment section of the questionnaire explored the presence of any
of the 18 listed self-reported chronic diseases with three additional options of “any other” as
reported by the patients (S1 Fig). The list of chronic conditions was prepared based upon the
findings from our pilot study, extensive literature review and expert consultations. To evaluate
depression, along with physician-diagnosed self-report, we included the Patient Health Ques-
tionnaire (PHQ-9) that is already validated for the Indian population[22]. The procedure for
depression was different as compared to the assessment of the other chronic diseases, because
the prevalence of depression in primary care in India is very low. For each of the reported
chronic illnesses, severity was recorded by asking how much the condition gets in the way of
their daily activities (e.g.: 0-not at all, a little, or 5- a great deal) [23]. Besides that for 10% of the
patients, prescriptions were checked for types of drug being consumed and counterchecked
with the wrapper of the drug/capsule.
The number of patients for each facility was calculated based on respective outpatient atten-
dance. Adult patients (aged more than 18 years) were recruited by systematic random sam-
pling and interviewed at exit from physician consultation. To avoid duplication, a unique
identification number was given to patients. Interviews were conducted by four well trained
field investigators with nursing background well versed with local language and patient history
taking. Each interview spanned from 20 to 30 minutes.
Data analysis
Three more chronic diseases were extracted from the additional list (S1 Fig) and added to the
previous list of 18 thus totaling to 21 chronic diseases. We followed the prescribed guidelines
for analysis of PHQ-9 towards diagnosing depression and a score of 10 or more was taken as a
cutoff value for depression[24].
Analysis was carried out using sampling weight which was calculated taking account of the
complex nature of the sample, i.e. different sampling fraction in each CHC or private facility
and taking account of clustering by facility by using the ‘svy’ command in STATA (Version
12.0, Stata crop, TX). Because of two-stage design nature, the probability weight is calculated
as f1f2, which means that the inverse of the sampling fraction for the first stage (i.e. using the
formula N/n, where N = the number of elements in the population and n = the number of ele-
ments in the sample) is multiplied by the inverse of the sampling fraction for the second stage.
Percentages in this paper are weighted and cluster adjusted. Confidence interval of the
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prevalence was calculated and chi-square test was performed for univariate analysis. We
defined ‘multimorbidity’ as the presence of any two or more co-occurring chronic or long
term diseases or conditions. Patterns (dyads and triads) were determined by employing a sim-
ple matrix approach exhaustive analysis of all possible combination of two or three co-morbid
conditions using a simple descriptive statistical method[25].
We included those conditions which had a prevalence of more than 0.5% for analysis,
below which the numbers of cases were negligible. Prevalence for single chronic condition
(mono-morbidity) and leading combinations of two (dyad) and three chronic conditions
(triad) was calculated for the whole study sample. Next, age specific prevalence of dyads and
triads in men and women was analyzed separately after stratifying them into three age groups
(18-39years, 40–64 years and65 years) separately. Age adjusted severity score for dyads and
triads was calculated by simple addition method and mean severity score was estimated for
single diseases, dyads and triads with higher score indicating increasing functional limitation
[23].
Ethical consideration
The study adhered to the Declaration of Helsinki principles and was approved by the Institu-
tional Ethics Committee of Public Health Foundation of India, New Delhi (Vide no.
TRC-IEC-173/13). Respective physicians in charge of the health facilities were contacted and
their permission was obtained in prior. Written informed consent was obtained from all
respondents following an explanation of the study aims and procedures. Necessary steps were
taken to preserve patient anonymity and confidentiality.
Results
A total of 1670 primary care patients were approached, of which 1649 agreed to participate
(response rate– 98%). The socio-demographic characteristics of the study participants are
depicted in Table 1. Out of 1649, 921 and 728 were men and women respectively representing
6128 men and 4682 women after considering sampling weight. Nearly 60% of the participants
were aged 40 or more and 28% were aboriginal. The average age of the study patients was
44.04 years [95% CI: 43.21–44.86]. The overall prevalence of multimorbidity was 28.3%. The
mean number of chronic conditions and the prevalence of multimorbidity was more among
women [32.5%] compared to men [25.1%] [X2 14.23, p = 0.047] whereas, the mean severity
score was higher among men [3.22, 95% CI 3.05–3.39] compared to women [3.15, 95%CI
2.97–3.33]. The total count of chronic conditions across age and gender is presented in Fig 1
which indicates there is increasing number of morbidities with age in both men and women.
Combination of co-morbid conditions
A. Distribution of single chronic condition (either alone or in combination). The prev-
alence of single chronic condition either as isolated or comorbidity across gender is shown in
Fig 2. In total, 439 individuals had isolated single chronic condition (men = 246,
women = 193). Among men (n = 913) the leading chronic conditions were acid peptic disease
(28.42%), hypertension (15.02%), arthritis (13.37%), chronic back ache (10.58%) and diabetes
(6.71%) whereas for women (n = 723) acid peptic disease (33.71%), hypertension (18.16%),
arthritis (17.92%), chronic back ache (13.10%) and visual impairment (6.85%) were found to
be leading.
B. Two chronic conditions. Around 15% of study participants had two chronic condi-
tions constituting 57.9% of all patients with multimorbidity. Table 2 denotes the age-wise dis-
tribution of the dyads for men and the same for women is given in Table 3. The dyads were
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almost similar for men and women. The combinations of acid peptic disease with arthritis/
chronic back ache/chronic lung disease were more common in younger age group i.e. 18–29
years older age groups had common combinations of hypertension + arthritis/ chronic lung
disease/vision difficulty, and arthritis + chronic back ache.
C. Triads (three chronic conditions). Out of 437 multimorbid patients, 107 (24.48%) had
three chronic conditions (men = 48, women = 59). Overall, the leading triads between men
and women were similar. Participants in older age group 40–64 years showed the highest num-
ber of triads (Fig 3). The prevalence of acid peptic disease + arthritis + chronic backache was
common in both younger and older age group in men. Among women, the leading triad was
acid peptic disease + arthritis + chronic backache (31.24%) in the younger age group while in
the older age group it was acid peptic disease + hypertension + arthritis (37.74%) (Fig 4)
D. Severity (functional limitation). Mean severity score within mono-morbidities was
highest for tuberculosis (TB) (2.81: 95% CI 2.40–3.22] followed by chronic lung disease [2.78:
95%CI 2.51–3.04] and heart disease [2.75: 95%CI 2.11–3.39]. The severity score was highest
for heart disease [3.07: 95%CI 2.22–3.91], TB [2.94: 95%CI 2.50–3.37] and deafness [2.71: 95%
CI 2.03–3.38] in men. Among women, arthritis [2.89: 95% CI 2.66–3.03], chronic lung disease
Table 1. Prevalence of multimorbidity, mean morbidity score and mean severity score across socio-demographic variables.
Characteristics Total (n = 1649)
(Weighted %)
Percentage with multimorbidity
(2conditions)
Weighted % [95%CI]
Mean number of
morbidity
[Range: 0–21]
Mean severity
score
[Range 0–5]
Age Group* 18–29 373[22.6] 5.8[1.99–9.6] 0.26[0.06] 2.50[0.32]
30–39 297[18.1] 22.2[15.1–29.4] 0.86[0.14] 2.91[0.28]
40–49 346[20.5] 24.3[17.7–30.9] 1.06[0.06] 3.35[0.27]
50–59 266[16.7] 36.2[27.9–44.5] 1.31[0.16] 3.19[0.27]
60–69 236[14.6] 36.9[28.1–45.8] 1.47[0.18] 3.40[0.26]
70 131[07.5] 44.4[33.0–55.8] 1.59[0.24] 3.47[0.40]
Gender* Man 921[55.8] 25.1[22.1–28.0] 0.91[0.08] 3.19[0.12]
Woman 728[44.2] 32.5[29.0–35.9] 1.08[0.08] 3.22[0.17]
Place of living Rural 1493[90.4] 25.5[23.2–27.8] 1.00[0.06] 3.42[0.11]
Urban 156[9.6] 28.5[27.8–29.3] 0.85[0.18] 3.21[0.09]
Ethnicity Aboriginal 471[28.0] 27.7[26.3–29.2] 0.96[0.14] 3.45[0.11]
Non aboriginal 1178[71.4] 28.5[27.6–29.4] 0.76[0.10] 3.51[0.10]
Socio-economic
status
Below poverty line 1035[61.6] 28.8[27.8–29.7] 0.92[0.06] 3.30[0.17]
Above poverty line 601[38.4] 27.5[26.2–28.8] 1.10[0.10] 2.99[0.15]
Schooling No School 642[38.1] 35.0[33.7–36.3] 0.98[0.10] 2.98[0.09]
Primary
completed
514[30.7] 28.3[27.1–29.5] 1.17[0.12] 3.42[0.19]
Secondary and
above
493[31.1] 20.1[19.6–21.1] 0.94[0.12] 3.21[0.17]
Marital Status Currently married 1321[79.8] 29.3[28.5–30.1] 0.25[0.08] 3.13[0.16]
Currently not
married
328[20.2] 24.3[22.0–26.6] 1.25[0.06] 3.65[0.18]
Facility Public 849[61.0] 28.1[27.1–29.1] 1.02[0.08] 3.15[0.18]
Private 800[39.0] 28.6[27.5–29.7] 0.93[0.08] 3.12[0.11]
Total 1649 28.3[25.9–30.7] 0.95[0.03] 3.15[0.05]
*The prevalence of multimorbidity across age group was adjusted for gender and across gender was adjusted for age, and for others, prevalence was
adjusted for age and gender.
https://doi.org/10.1371/journal.pone.0183966.t001
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[2.85: 95%CI 2.50–3.19] and chronic back ache [2.68: 95% CI 2.47–2.89] had leading mean
severity score.
Among the dyads, arthritis + chronic back ache [5.49: 95%CI 4.89–6.06], chronic backache
+ vision impairment [5.31: 95%CI 3.81–5.81] arthritis + chronic lung disease [5.07: 95% CI
[4.01–6.12], acid peptic disease + chronic backache [4.94: 95%CI 4.91–4.97] and acid peptic
disease + arthritis [4.9: 95%CI 4.88–4.92] had highest burden score. Among men, arthritis
+ chronic backache [5.59: 95%CI 5.10–5.76] acid peptic disease + chronic lung disease [5.3:
95% CI 5.1–5.4] and chronic backache and vision impairment [5.03: 95%CI 4.98–5.08] were
observed to have highest activity limitation (Fig 5). In women, chronic backache+ vision
impairment, hypertension + chronic backache, hypertension + chronic lung disease and
hypertension and diabetes had highest severity score (Fig 5). Within triads the leading condi-
tions in terms of severity were found to be arthritis+ chronic backache+ vision impairment
[8.38], acid peptic disease+ arthritis +chronic backache [8.22], hypertension + arthritis
+ chronic backache [7.96] and acid peptic disease + hypertension + diabetes [7.75] (Fig 6).
Discussion
Multimorbidity, with its range of adverse consequences is arguably the greatest health care
challenge globally. Such patients exhibit greater complexity, with different coexisting illnesses
often simultaneously exacerbating the other thus leading to frequent physician consultation,
longer hospitalizations, and higher health care costs with inferior quality of life[26]. Despite the
global pervasiveness of multimorbidity limited studies have explored the combinations or pat-
tern of diseases within the ambit of multimorbidity in LMIC[27]. Against this view, we exam-
ined both prevalence and patterns of multimorbidity among patients attending primary care in
Odisha. We found multimorbidity to be common among primary care patients (proportion
28.9%) similar to western and other middle income countries[28–31]. For instance, a study in
Ghana has identified 38.8% outpatients to have multimorbidity, while another study from Bra-
zil has reported the prevalence to be 29.1% among adult population[30,31]. A recent study in
Fig 1. Number of chronic conditions in three age groups.
https://doi.org/10.1371/journal.pone.0183966.g001
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Fig 2. Prevalence of chronic condition (any and isolated) across gender.
https://doi.org/10.1371/journal.pone.0183966.g002
Multimorbidity pattern in Odisha, India
PLOS ONE | https://doi.org/10.1371/journal.pone.0183966 September 14, 2017 8 / 19
Table 2. Prevalence (%) of dyads among men.
18-39Yrs (N = 364)
(Weighted %)
40-64Yrs
(N = 425)
(Weighted %)
65Yrs
(N = 132)
(Weighted %)
Total
(N = 921)
APD+HTN 2.82 9.64 10.21 7.02
APD+ART 4.3 9 14.78 7.95
APD+CBA 3.71 7.92 10.6 6.63
ART+CBA 1.93 5.16 17.24 5.57
HTN+ART 0.91 4.12 11.82 3.92
HTN+DI 0.96 4 6.63 3.21
APD+VI 1.43 3.72 6.38 3.18
HTN+CBA 0.92 4.04 7.38 3.27
ART+VI 1.12 2.24 5.13 2.2
APD+DI 0.31 2.96 0.97 1.64
HTN+VI 0.18 1.36 4.69 1.36
ART+DI 0.5 0.99 3.16 1.1
APD+CLD 0.11 1.05 1.46 0.73
APD+DF 0 0.7 1.51 0.56
HTN+CLD 0.18 0.52 1.61 0.54
[APD- Acid peptic disease; HTN-Hypertension; ART-Arthritis; DI-Diabetes; CBA-Chronic backache; VI- Visual impairment; DF- Deafness; CLD- Chronic
lungs disease]
https://doi.org/10.1371/journal.pone.0183966.t002
Table 3. Prevalence (%) of dyads among women.
18-39Yrs (N = 306)
Weighted %
40-64Yrs
(N = 337) (Weighted %)
65Yrs
(N = 85) (Weighted %)
Total
(N = 721)
APD+HTN 3.29 17.13 11.32 10.58
APD+ART 3.38 13.8 20.79 10.24
APD+CBA 4.83 10.48 10.14 8.05
ART+CBA 1.06 9.75 11.05 6.23
HTN+ART 0.48 7.36 12.73 5.1
APD+VI 1.18 6.8 5.07 4.22
ART+VI 0.54 4.48 10.02 3.48
HTN+CBA 0.31 3.96 5.34 2.58
HTN+DI 0 3.11 4.94 2.11
APD+DI 0.27 3.49 3.11 2.09
HTN+VI 0 3.34 3.72 1.97
ART+DI 0.46 1.76 6.2 1.74
APD+LD 0.62 2.73 0.77 1.6
APD+DF 0.59 1.24 2.68 1.14
HTN+CLD 0 1.84 0.77 0.93
APD+HYP 0.48 0.64 1.25 0.78
ART+CLD 0 0.29 2.85 0.47
[APD- Acid peptic disease; HTN-Hypertension; HYP-Hypotension; ART-Arthritis; DI-Diabetes; CBA-Chronic backache; VI- Visual impairment; DF-
Deafness; CLD- Chronic lungs disease]
https://doi.org/10.1371/journal.pone.0183966.t003
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South India has also demonstrated similar prevalence figures thus demonstrating the rising
burden of multimorbidity in LMIC and no longer a restriction to wealthier countries[32].
Frequently occurring chronic conditions
In our study, acid peptic disease (APD) was found to be the most common condition either
alone or with other chronic diseases. This contra posits with most western findings where
reports tend to be much lower (3%-8%). Hypertension and arthritis were the most frequently
observed chronic condition. Available studies from LMIC have found hypertension and arthri-
tis to be the most frequently occurring comorbidities [12,28,29]. However, one community
survey done in India had identified the prevalence of APD to be considerably high which reso-
nates with our findings[33,34]. Since both diagnosis and management of APD is done at pri-
mary care level most patients might be visiting primary care practice for such ailments.
Arthritis, diabetes, hypertension and chronic lung diseases were found to be other leading
chronic diseases, in congruence with other studies[15]. The increased proportion of hyperten-
sion and diabetes could be due to increased health literacy among patients, better symptom
appraisal by primary care physicians and availability of diagnostic facilities under the national
Fig 3. Prevalence (%) of triads among men.
https://doi.org/10.1371/journal.pone.0183966.g003
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Fig 4. Prevalence (%) of triads among women.
https://doi.org/10.1371/journal.pone.0183966.g004
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Fig 5. Severity score for dyad chronic conditions [Score range 0–10].
https://doi.org/10.1371/journal.pone.0183966.g005
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non communicable disease control program which primarily focuses on diabetes and hyper-
tension. We found high prevalence of arthritis and lung diseases in primary care in coherence
with other studies from India as well as LMIC[29–31,35]. However, the national NCDs control
program is yet to incorporate these conditions in their priorities.
Fig 6. Severity score for triad chronic conditions.
https://doi.org/10.1371/journal.pone.0183966.g006
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Combination of chronic conditions
We classified the combinations (dyads and triads) and assessed their clinical relevance by
the plausibility of disease interactions. The coexisting conditions may be concordant that ema-
nate from the same pathophysiology, or discordant conditions arising from separate patho-
physiologies[36]. Multimorbidity patterns have traditionally been classified into three
cumulative categories: simple co-/multimorbidity (the co-occurrence of diseases, whether
coincidental or not), associative co-/multimorbidity (statistical association, not or not known
to be causal); and causal co-/multimorbidity (implying a causal relation among co-occurring
diseases) [2].
Despite the inclusion of 21 diseases in multimorbidity assessment, most dyads (having pro-
portion of more than one percent) were confined to 10 conditions. From 16 dyads identified,
two were causal, eight were simple multimorbidity and six were associative in nature. Acid
peptic diseases was present in 50% dyads while hypertension and arthritis each contributed to
40% followed by 20% dyads having diabetes, chronic backache and chronic lungs diseases as a
comorbidity.
Given the absence of similar studies from primary care settings it is challenging to compare
our findings within South Asia. However, our proportion of causal comorbidities was near
similar to that observed in western countries[37,38]. The coexistence of hypertension and dia-
betes has been widely documented. Both share similar risk factors and clustered under meta-
bolic syndrome[39]. Contrastingly, there is scanty evidence available on concurrent presence
of hypertension and chronic lung diseases[40]. One plausibility could be the bronchospasm
induced by prolonged use antihypertensive medications[41]. To explore such association
future studies need to be done. Mostly, the therapeutic guidelines are available for individual
diseases especially, hypertension, diabetes and asthma. Given the commonly occurring dyads,
it is imperative that the primary care protocols should be designed to accommodate causal co-
morbidities as well.
Associated comorbidities arise because of the therapeutic impacts or consequences of the
primary or index diseases. In our study, acid peptic disease was predominantly coexistent with
arthritis, chronic back ache and hypertension. The relationship between musculoskeletal dis-
eases and APD is well evident[42]. Non-Steroidal Anti Inflammatory Drugs (NSAIDs) known
to have both upper and lower gastrointestinal tract erosions are routinely prescribed for a vari-
ety of musculoskeletal complaints such as arthritis, chronic back ache, and short-term manage-
ment of pain[43,44]. More so over the counter prescription of NSAID is a common practice in
India which could have been another contributory reason[45,46]. Similarly, calcium channel
blockers and beta blockers prescribed for hypertension may aggravate or precipitate gastroin-
testinal reflux leading to increased prevalence of APD[47].
Acid peptic disease was coexisting with deafness, chronic lung diseases and vision
impairment thus sharing 50% of the total discordant pattern. Another major discordant com-
bination was arthritis or chronic back ache with hypertension. Such combinations could be
resulting from the interplay of multiple factors such as increase in age, obesity and/or seden-
tary life style. The knowledge of chronological occurrence of the diseases could have been par-
tially able to explain the pattern. For example, limitation of physical activities in arthritis might
predispose hypertension; on the other hand, increased body weight or sedentary life style can
potentiate the risk of arthritis and hypertension[48]. Similarly, presence of vision impairment
in hypertension either be induced by hypertension or related to age. Since we had not collected
information on exact reasons of vision problems at primary care facilities, it is difficult to
ascertain the probable causes. Further studies should strive to identify any plausible biological
or etiological factors underlying such discordant patterns.
Multimorbidity pattern in Odisha, India
PLOS ONE | https://doi.org/10.1371/journal.pone.0183966 September 14, 2017 14 / 19
Severity of the pattern
We estimated age adjusted severity score for all dyads and triads. The mean severity score
among dyads ranged from 4.39 to 5.49 [normal range 2–10] and 6.03 to 8.38 for triads [normal
range 3–15]. Even though the disease count was two, the variation in age adjusted severity
score explains the importance of typology of co morbidities. For example we found that, in
dyads, presence of arthritis, chronic back ache and chronic lung diseases with other conditions
inflates the burden score indicating functional limitations. Diseases having clear manifesta-
tions of physical symptoms impact the activity of daily living of a patient more, than diseases
like hypertension and diabetes. It is evident that, such physical symptoms like pain in joints or
breathing problem affects an individual’s activities thus impairing the quality of life[49]. Our
study also reveals the high functional limitation accruing from musculoskeletal disorders,
which advocates for availability for the musculoskeletal care in primary care setting in India.
Implication for future research, health care policy and practice
In persons with multimorbidity, there exists co-occurrence of diseases beyond chance, which
clinicians need to take into account in their daily practice. We found few emerging, unex-
pected non-random associations that may not logically follow previous biomedical research
but that offer promising directions for future research. Some pathological mechanisms behind
the identified clusters are well-known (for instance diabetes and hypertension; diabetes and
cardiovascular diseases); other combinations (COPD and arthritis) need further clarification
to identify possible preventative strategies. Even though age is seen to play a crucial role in
determining the combination of diseases, the variety of patterns in reported in the younger age
group necessitates future research to identify the biomarkers or linking factors. Regarding the
clinical applicability of these findings, apart from generating new hypotheses on possible
shared pathophysiological pathways among specific diseases, research on multimorbidity pat-
terns may orient prevention and optimal management (including treatment decisions) for
individuals suffering from a given index disease who develop successive conditions. Moreover,
certain combinations were found to be associated with higher functional decline, underscoring
the importance of global assessment of multimorbid patients for functional limitations. Fur-
ther research, preferably of longitudinal design, should investigate the possible causal underly-
ing mechanisms, trajectory, clinical impact and the financial implications of these associations
so as to predict health care needs and reduce the adverse health impacts in patients.
Effective management of multimorbidity is challenging in primary care practice[50]. Physi-
cians and patients can be overwhelmed by the need to address comorbid chronic conditions in
addition to patients’ disease specific treatment goals. Therefore while managing concurrent
diseases it is imperative to consider severity (functional limitation) for effective control of the
disease and improve patients’ quality of life. Current national NCD program should design
customized or tailor made disease or case management protocols for patients with multiple
morbidities, as most of the patients might be consulting individual providers thus resulting in
fragmented care and suboptimal outcomes. Firstly, specific treatment guidelines or patient
education programs could be developed for persons with high-frequency clusters or with clus-
ters of diseases particularly difficult to be treated. Further, evidence based research on better
care model for patients with multimorbidity to reduce the potential for drug–drug and drug–
disease interactions should be initiated.
Strengths and limitations
Our work for the first time reveals the multimorbidity patterns present among primary care
patients and indicates the complex heterogeneous problems of the same in India. However, we
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restricted the patients to primary settings and the magnitude may be more or less in secondary
and tertiary care facilities. Further, being of cross sectional nature, the causal and trajectory
cannot be assessed. We ascertained multimorbidity through self-reports which may be prone
to recall bias. Nonetheless, the validity and reliability of self-report is well established in our
previous study[20]. Despite these limitations, our study provides a very timely contribution to
the current understanding of clustering and severity of multiple chronic diseases and, in par-
ticular, provides important insights into approaches to designing care strategies for such
patients in Indian context. Findings from our study have significant implications for program
planners, general practitioners, and policy-makers, valuable information relating to compre-
hensive and coordinated management of chronic disease and the delivery of primary care ser-
vices in India.
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